St. Clair Gregory Sr. has reported acquiring 733 shares of Axe Compute Inc. as compensation for his service on the company's board of directors. This acquisition, detailed in a recent SEC filing, highlights Gregory's ongoing involvement with the company and reflects the dynamic nature of leadership within the finance services sector.
Axe Compute Inc., the issuer of the shares, is classified under the finance services sector. The company, which operates out of Pittsburgh, Pennsylvania, has undergone several name changes in recent years, previously known as Predictive Oncology Inc. and Precision Therapeutics Inc. This evolution indicates a strategic pivot towards the rapidly changing landscape of finance and technology.
The SEC filing, accession number 0001171843-26-006423, reveals that the shares were issued on October 1, 2026, and that Gregory now owns a total of 18,299 shares following this transaction. The filing specifies that the shares were issued as part of his compensation for serving on the board, emphasizing the importance of board members in guiding company strategy and performance.
This update may affect various stakeholders, including investors and analysts who monitor the company's governance and financial health. Gregory's role as a director suggests he will have a significant influence on the company's strategic decisions moving forward.
Details regarding future actions or upcoming filings were not specified in the current filing. However, stakeholders will likely keep a close watch on Axe Compute Inc.'s developments as they navigate the complexities of the finance services industry.